Home
Live
News
Create
Screeners
Insights
Pharmaids Pharmaceuticals
61.
75
-0.43
(-0.69%)
Market Cap
₹217.78 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.69%
1M
-2.33%
6M
-12.65%
1Y
+51.57%
5Y
+1,387.95%
View Company Insights
Latest news about Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals Completes Rs 19.56 Crore Land Sale to Chairman
1 day ago
Pharmaids Pharmaceuticals Limited has sold three land parcels totaling 13,975 square meters in Karnataka's Hirehalli Industrial Area to its Chairman, Dr. S. N. Vinaya Babu, for Rs 19.56 crores. The transaction, completed on September 6, 2025, received necessary approvals including shareholder approval via postal ballot and Board of Directors' approval. The company states this sale will not affect its business operations. Following the transaction, Dr. Babu has made an open offer to public shareholders and will be reclassified as part of the Promoter/Promoter Group upon completion of the offer. The company has complied with all relevant regulatory requirements.
Pharmaids Pharmaceuticals Open Offer: Acquirers Seek 26% Stake at Rs. 62.15 Per Share
Aug 07, 2025
Open Offer for Pharmaids Pharmaceuticals at ₹62.15 per Share
Aug 07, 2025
Shankarappa Nagaraja Vinaya Babu Launches Open Offer for 26% Stake in Pharmaids Pharmaceuticals at ₹62.15 Per Share
Jul 25, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation